COVID-19 child vaccination: safety and ethical concerns – HART

EMF does not buy into the fear hysteria of COVID-19,
nor agree with the agenda of mandatory mRNA vaccinations.
User avatar
David McCarthy
Site Admin
Posts: 2892
Joined: Sun Jan 06, 2008 1:09 am
Location: New Zealand
Contact:

COVID-19 child vaccination: safety and ethical concerns – HART

Unread post by David McCarthy »

COVID-19 child vaccination: safety and ethical concerns – HART


May 20, 2021
An open letter from UK doctors to Dr June Raine, Chief Executive, MHRA

--------------------------------------------------------------------------------

Dr Ros Jones
Lead signatory Dr Ros Jones
Retired Consultant Paediatrician

Any medics or scientists who want to sign this open letter should email their name, qualifications and job title to: sign@hartgroup.org
We wish to notify you of our grave concerns regarding all proposals to administer COVID-19 vaccines to children. Recently leaked Government documents suggested that a COVID-19 vaccine rollout in children over 12 years old is already planned for September 2021, and the possibility of children as young as 5 years old being vaccinated in the summer in a worst-case scenario.1

We have been deeply disturbed to hear several Government and SAGE representatives calling in the media for the COVID-19 vaccine rollout to be “turning to children as fast as we can”.2 Teaching materials circulated to London schools contain emotionally loaded questions and inaccuracies3. In addition, there has been disturbing language used by teaching union leaders, implying that coercion of children to accept the COVID-19 vaccines through peer pressure in schools was to be encouraged, despite the fact that coercion to accept a medical treatment is against UK and International Laws and Declarations.4 Rhetoric such as this is irresponsible and unethical, and encourages the public to demand the vaccination of minors with a product still at the research stage and about which no medium- or long-term effects are known, against a disease which presents no material risk to them. A summary of our reasons is given below and a more detailed fully referenced explanation is available.5

Risks and benefits in medical treatments
Vaccines, like any other medical treatment, come with varied risks and benefits. Therefore, we must consider each product, individually, on its merits, and specifically for which patients or sections of the population is the risk/benefit ratio acceptable. For COVID-19 vaccines, the potential benefits are clear for the elderly and vulnerable, however, for children, the balance of benefit and risk would be quite different. We are raising these concerns as part of an informed debate, which is a vital part of the proper, scientific process. We must ensure that there is no repeat of any past tragedies which have occurred especially when vaccines are rushed to market. For example, the swine flu vaccine, Pandemrix, rolled out following the pandemic of 2010, resulted in over one thousand cases of narcolepsy, a devastating brain injury, in children and teenagers, before being withdrawn.6 Dengvaxia, a new vaccine against Dengue, was also rolled out to children ahead of the full trial outcomes, and 19 children died of possible antibody dependent enhancement (ADE) before the vaccine was withdrawn.7 We must not risk a repeat of this with the COVID-19 vaccines, which would not only impact on the children and families affected, but would also have a hugely damaging effect on vaccination uptake in general.

No medical intervention should be introduced on a ‘one size fits all’ basis, but instead should be fully assessed for suitability according to the characteristics of the age cohort and of the individuals concerned, weighing up the risk versus benefit profile for each cohort and the individuals within a group. This approach was outlined last October, by the head of the Government Vaccine Task Force, Kate Bingham, who said “We just need to vaccinate everyone at risk. There’s going to be no vaccination of people under 18. It’s an adult-only vaccine, for people over 50, focusing on health workers and care home workers and the vulnerable.”8

Children do not need vaccination for their own protection
Healthy children are at almost no risk from COVID-19, with risk of death as low as 1 in 2.5 million9. No previously healthy child under the age of 15 died during the pandemic in the UK and admissions to hospital or intensive care are exceedingly rare10 with most children having no or very mild symptoms. Although Long-Covid has been cited as a reason for vaccinating children, there is little hard data. It appears less common and much shorter-lived than in adults and none of the vaccine trials have studied this outcome11 12. The inflammatory condition, PIMS, was listed as a potential adverse effect in the Oxford AstraZeneca children’s trial13. Naturally acquired immunity will give broader and better lasting immunity than vaccination14. Indeed, many children will already be immune15. Individual children at very high risk can already receive vaccination on compassionate grounds16.

Children do not need vaccination to support herd immunity
Already, two thirds of the adult population have received at least one dose of a COVID-19 vaccine17. Models that assume vaccination of children is required to reach herd immunity have failed to account for the proportion who had immunity prior to March 2020 and those who have acquired it naturally18. Recent modelling suggested that the UK had achieved the required herd immunity threshold on 12 April 2021.19

Children do not transmit SARS-CoV-2 as readily as adults, moreover adults living or working with young children are at lower risk of severe COVID-1920. Schools have not been shown to be the focus on spread to the community, teachers have a lower risk of COVID-19 than other working age adults21.

Short-term safety concerns
As of 13th May, the MHRA22 has received a total of 224,544 adverse events, including 1,145 deaths in association with SARS-CoV-2 vaccines. Reports of strokes due to cerebral venous thromboses were initially in low numbers but as awareness increased, many more reports led to the conclusion that AstraZeneca vaccine should not be used for adults under 40 years of age and this unpredicted finding has also led to the suspension of the Oxford AstraZeneca children’s trial.

Similar events have been noted with Pfizer & Moderna vaccines on the US adverse reporting system (VAERS)23 and it is likely that this is a class effect related to production of spike protein. New UK guidelines on managing Vaccine-Induced Thrombotic Thrombocytopenia (VITT)24 include all COVID-19 vaccines in their advice. The possibility of further unexpected safety issues cannot be ruled out. In Israel, where the vaccines have been widely rolled out to young people and teenagers, the Pfizer vaccine has been linked to several cases of myocarditis in young men25 and concerns have been raised about reports of altered menstrual cycles and abnormal bleeding in young women following the vaccine.26

Most concerning with regard to possible vaccination of children, is that there have now been a number of deaths associated with vaccination reported to VAERS in the US, despite the vaccines only being given to children within trials and a very recent rollout to 16-17 year olds27.

Long-term safety concerns
All Phase 3 COVID-19 vaccine trials are ongoing and not due to conclude until late 2022/early 2023. The vaccines are, therefore, currently experimental with only limited short-term and no long-term adult safety data available. In addition, many are using a completely new mRNA vaccine technology, which has never previously been approved for use in humans28. The mRNA is effectively a pro-drug and it is not known how much spike protein any individual will produce. Potential late-onset effects can take months or years to become apparent. The limited children’s trials undertaken to date are totally underpowered to rule out uncommon but severe side effects.

Children have a lifetime ahead of them, and their immunological and neurological systems are still in development, making them potentially more vulnerable to adverse effects than adults. A number of specific concerns have been raised already, including autoimmune disease and possible effects on placentation and fertility.29 A recently published paper raised the possibility that mRNA COVID-19 vaccines could trigger prion-based, neurodegenerative disease30. All potential risks, known and unknown, must be balanced against risks of COVID-19 itself, so a very different benefit/risk balance will apply to children than to adults.

Conclusion
There is important wisdom in the Hippocratic Oath which states, “First do no harm”. All medical interventions carry a risk of harm, so we have a duty to act with caution and proportionality. This is particularly the case when considering mass intervention in a healthy population, in which situation there must be firm evidence of benefits far greater than harms. The current, available evidence clearly shows that the risk versus benefit calculation does NOT support administering rushed and experimental COVID-19 vaccines to children, who have virtually no risk from COVID-19, yet face known and unknown risks from the vaccines. The Declaration of the Rights of the Child states that, “the child, by reason of his physical and mental immaturity, needs special safeguards and care, including appropriate legal protection”.31 As adults we have a duty of care to protect children from unnecessary and foreseeable harm.

We conclude that it is irresponsible, unethical and indeed, unnecessary, to include children under 18 years in the national COVID-19 vaccine rollout. Clinical trials in children also pose huge ethical dilemmas, in light of the lack of potential benefit to trial participants and the unknown risks. The end of the current Phase 3 trials should be awaited as well as several years of safety data in adults, to rule out, or quantify, all potential adverse effects.

We call upon our governments and the regulators not to repeat mistakes from history, and to reject the calls to vaccinate children against COVID-19. Extreme caution has been exercised over many aspects of the pandemic, but surely now is the most important time to exercise true caution – we must not be the generation of adults that, through unnecessary haste and fear, risks the health of children.

Signatories

Dr Rosamond Jones, MD, FRCPCH, retired consultant paediatrician
Lord Moonie, MBChB, MRCPsych, MFCM, MSc, House of Lords, former parliamentary undersecretary of state 2001-2003, former consultant in Public Health Medicine
Prof Anthony Fryer, PhD, FRCPath, Professor of Clinical Biochemistry, Keele University
Professor Karol Sikora, MA, MBBChir, PhD, FRCR, FRCP, FFPM, Dean of Medicine, Buckingham University, Professor of Oncology
Professor Angus Dalgleish, MD, FRCP, FRACP, FRCPath, FMed Sci, Professor of Oncology, St Georges Hospital, London
Professor Richard Ennos, MA, PhD. Honorary Professorial Fellow, University of Edinburgh
Professor Anthony J Brookes, Department of Genetics & Genome Biology, University of Leicester
Professor Keith Willison, PhD, Professor of Chemical Biology, Imperial, London
Dr John A Lee, MBBS, PhD, FRCPath, retired Consultant Histopathologist, former Clinical Professor of Pathology at Hull York Medical School
Professor John A Fairclough, BM BS, BMed Sci, FRCS, FFSEM(UK), Professor Emeritus, Honorary Consultant Orthopaedic Surgeon
Dr Alan Mordue, MBChB, FFPH (ret). Retired Consultant in Public Health Medicine & Epidemiology
Dr Elizabeth Evans, MA, MBBS, DRCOG, retired doctor
Mr Malcolm Loudon, MB ChB, MD, FRCSEd, FRCS (Gen Surg). MIHM, VR. Consultant Surgeon
Dr Gerry Quinn, PhD, Microbiologist
Dr C Geoffrey Maidment, MD, FRCP, retired consultant physician
Dr K Singh, MBChB, MRCGP, general practitioner
Dr Pauline Jones MB BS retired general practitioner
Dr Holly Young, BSc, MBChB, MRCP, Consultant physician, Croydon University Hospital
Dr David Critchley, BSc, PhD, 32 years in pharmaceutical R&D as a clinical research scientist.
Dr Padma Kanthan, MBBS, General practitioner
Dr Thomas Carnwath, MBBCh,MA, FRCPsych, FRCGP, consultant psychiatrist
Dr Sam McBride BSc(Hons) Medical Microbiology & Immunobiology, MBBCh BAO, MSc in Clinical Gerontology, MRCP(UK), FRCEM, FRCP(Edinburgh). NHS Emergency Medicine & geriatrics
Dr Helen Westwood MBChB MRCGP DCH DRCOG, general practitioner
Dr M A Bell, MBChB, MRCP(UK), FRCEM, Consultant in Emergency Medicine, UK
Mr Ian F Comaish, MA, BM BCh, FRCOphth, FRANZCO, Consultant ophthalmologist
Dr Jayne LM Donegan MBBS, DRCOG, DCH, DFFP, MRCGP, general practitioner
Dr Dayal Mukherjee, MBBS MSc
Dr Clare Craig, BM,BCh, FRCPath, Pathologist
Mr C P Chilton, MBBS, FRCS, Consultant urologist emeritus
Dr Theresa Lawrie, MBBCh, PhD, Director, Evidence-Based Medicine Consultancy Ltd, Bath
Dr Jason Lester, MRCP, FRCR, Consultant Clinical Oncologist, Rutherford Cancer Centre, Newport
Dr Scott McLachan, FAIDH, MCSE, MCT, DSysEng, LLM, MPhil., Postdoctoral researcher, Risk & Information management Group
Michael Cockayne, MSc, PGDip, SCPHNOH, BA, RN, Occupational health practitioner
Dr John Flack, BPharm, PhD. Retired Director of Safety Evaluation at Beecham Pharmaceuticals 1980-1989 and Senior Vice-president for Drug Discovery 1990-92 SmithKline Beecham
Dr Stephanie Williams, Dermatologist
Dr Greta Mushet, retired Consultant Psychiatrist in Psychotherapy. MBChB, MRCPsych
Dr JE, MBChB, BSc, NHS hospital junior doctor
Mr Anthony Hinton, MBChB, FRCS, Consultant ENT surgeon, London
Dr Elizabeth Corcoran, MBBS,MRCPsych,Psychiatrist,Chair Down’s Syndrome Research Foundation UK
Dr Alan Black, MB BS MSc DipPharmMed, retired pharmaceutical physician
Dr Christina Peers, MBBS,DRCOG,DFSRH,FFSRH, Consultant in Contraception & Reproductive Health
Dr Marco Chiesa, MD, FRCPsych, Consultant Psychiatrist & Visiting Professor, UCL
Elizabeth Burton, MB ChB, retired general practitioner
Noel Thomas, MA, MB ChB, DCH, DObsRCOG, DTM&H, MFHom, retired doctor
Malcolm Sadler, MBBS, FRCGP, retired general practitioner with 37 years in Medical Practice
Dr Ian Bridges, MBBS, Retired general practitioner
Mr T James Royle MBChB, FRCS(Ed), MMedEd, Consultant colorectal surgeon
Dr Fiona Martindale, MbChB, MRCGP, GP in out of hours
Dr Karen Horridge, MB ChB(Hons), MSc, MRCP, FRCPCH, Consultant Paediatrician (Disability)
Mr Christian Duncan, Consultant Plastic Surgeon, MB BCh, BAO, MPhil, FRCSI, FRCS (Plast)
Dr David Bramble, MBChB, MRCPsych, MD. Consultant Psychiatrist
Dr Jessica Robinson, BSc(Hons), MBBS, MRCPsych, MFHom, Psychiatrist & Integrative Medicine Doctor
Katherine MacGilchrist, BSc (Hons) Pharmacology, MSc Epidemiology, CEO, Systematic Review Director, Epidemica Ltd
David Halpin MB BS, FRCS, Orthopaedic and trauma surgeon (retired)
Jemma Dale, BSc (Hons), Biomedical Scientist
Dr Helen Macklin, MBBS, DRCOG, MRCGP, general practitioner
Dr Mark Atkinson, MBBS, BSc (Hons), FRSPH. Retired Medical Doctor
Dr Anne Renfrew, MB ChB, MRCOG, MRCGP, DCH, Retired general practitioner
Dr S Allam, MB ChB, FRCA, Consultant Anaesthetist, UK
Dr David Morris, MBChB, MRCP(UK), General Practitioner
Dr. Peter Chan, BM, MRCS, MRCGP, General Practitioner, Functional medicine practitioner
Dr Sam White, MBChB, MRCGP, General Practitioner, Functional medicine practitioner
Dr Rohaan Seth, MBChB, BSc, MRCGP, General Practitioner

Endnotes

1. https://www.dailymail.co.uk/news/articl ... ember.html
2. https://www.dailymail.co.uk/news/articl ... gence.html
3. Critical Thinking Assembly on Vaccines
4. https://www.telegraph.co.uk/news/2021/0 ... s-saypeer/
5. https://www.hartgroup.org/wp-content/up ... cument.pdf
6. https://www.narcolepsy.org.uk/resources ... narcolepsy
7. https://www.sciencemag.org/news/2019/04 ... hilippines
8. https://www.ft.com/content/d2e00128-788 ... e51355a751
9. https://gh.bmj.com/content/bmjgh/5/9/e003094.full.pdf
10. https://doi.org/10.1136/bmj.m3249
11. Illness duration and symptom profile in a large cohort of symptomatic UK school-aged children tested for SARS-CoV-2
12. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease
13. https://www.hartgroup.org/wp-content/up ... eb2021.pdf
14. https://www.nature.com/articles/s41586-021-03207-w
15. https://science.sciencemag.org/content/370/6522/1339
16. https://www.gov.uk/government/publicati ... ember-2020
17. Vaccinations | Coronavirus in the UK (data.gov.uk)
18. https://www.bmj.com/content/370/bmj.m35 ... Do0a6Tsrto
19. Britain will achieve herd immunity by Monday, according to UCL
20. Sharing a household with children and risk of CO VID-19: a study of over 300,000 adults living in healthcare worker households in Scotland
21. https://publichealthscotland.scot/media ... er2020.pdf
22. https://www.gov.uk/government/publicati ... -reactions
23. https://vaers.hhs.gov/data.html
24. Guidance produced from the Expert Haematology Panel (EHP) focussed on Covid-19 Vaccine induced Thrombosis and Thrombocytopenia
25. https://www.timesofisrael.com/israel-sa ... nunder-30/
26. https://www.haaretz.com/israel-news/.pr ... -1.9754865
27. https://vaers.hhs.gov/data.html
28. https://www.immunology.org/coronavirus/ ... r-covid-19
29. https://www.nature.com/articles/s41579-020-00462-y
30. https://scivisionpub.com/pdfs/covid19-r ... e-1503.pdf
31. https://www.ohchr.org/en/professionalin ... s/crc.aspx



COVID-19 child vaccination: safety and ethical concerns – HART
https://www.hartgroup.org/open-letter-c ... ccination/
But he has nothing on at all, cried at last the whole people....
User avatar
David McCarthy
Site Admin
Posts: 2892
Joined: Sun Jan 06, 2008 1:09 am
Location: New Zealand
Contact:

HART - Who are we?

Unread post by David McCarthy »


HART Who are we?
HART is a group of highly qualified UK doctors, scientists, economists, psychologists and other academic experts. We came together over shared concerns about policy and guidance recommendations relating to the COVID-19 pandemic.

We continue to be concerned about the lack of open scientific debate in mainstream media and the worrying trend of censorship and harassment of those who question the narrative. Science without question is dogma.

Specifically, we identify a need for public policy to reflect a broader and more balanced approach across a number of key areas, such as:

Impact of masks and mandatory lockdowns on wider society;
Assessment of the long-term impact of school and university closures;
Re-evaluation of the evidence on transmission and the role of asymptomatic spread;
Re-evaluation of diagnostic testing, track and trace and associated data analysis;
The psychological impact of the government’s COVID-19 advertising campaigns (in particular the ‘sick until proven healthy’ directives);
An urgent evaluation of the evidence base for safe and effective (non-vaccine) medicines to treat and prevent illness from SARS-CoV-2 and its variants, and more research where considered necessary.
HART spokespeople
Dr John Lee
Retired Professor of Pathology
John is a retired English pathologist who was formerly Clinical Professor of Pathology at Hull York Medical School and Consultant Histopathologist at Rotherham General Hospital, later becoming the Rotherham NHS Foundation Trust’s Director of Cancer Services.

Dr Lee became known to a wider public after co-presenting Anatomy for Beginners (screened in the UK on Channel 4 in 2005).

Dr John Lee
Dr Gordon Hughes
Former Professor of Political Economy, University of Edinburgh and former Chairman of the Water Industry Commission for Scotland
Gordon was Professor of Political Economy at the University of Edinburgh from 1985 until 1991, and has been a visiting professor ever since.

Gordon has led/directed many studies and advisory projects in environmental epidemiology, health economics and related areas.

Dr Gordon Hughes
Dr Ros Jones
Retired Consultant Paediatrician
Ros is a retired Consultant Paediatrician with a special interest in neonatal intensive care and paediatric HIV. She has served on the Advisory Committee of the National Perinatal Epidemiology Unit and on the Education & Training committee of the RCPCH.

An active member for many years in the British Perinatal Trials Group, she was also involved in reviewing NICE guidelines alongside some time editorial. Since retiring from the NHS, she has undertaken several tours teaching on SAFE Obstetrics courses in countries in Africa.

Dr Ros Jones
Alfie Carlisle – HART Young People’s Spokesperson
Law Student and SU Trustee
Alfie is a Law student at the University of Exeter. Having read constitutional and human rights law, he is primarily interested in the behaviour of the state throughout the pandemic and the possible impacts on citizens’ human rights.

Alongside this, he is a trustee of the Exeter Students’ Guild, so is regularly exposed to the issues students face as a direct result of restrictions and a suspension of face-to-face teaching.

Alfie Carlisle
Members – Medicine, Science & Data
Isabella Cooper FnDNutr., BSc (Hons), AFHEA, AMRSB, AfENDO
Doctoral Researcher
Isabella majored with honours in biochemistry with medical physiology, molecular genetics, advanced cell biology, advanced cancer biology, physiological networks (neurology, endocrinology and immunology), proteins and enzyme biochemistry, bioinformatics in influenza, and metabolic biochemistry. She has won multiple awards including the Faculty of Science and Technology Awards, Individual Teaching Award and Group Teaching Award for Medical Physiology, Dean’s List Awards and Biochemical Society Award.

Isabella is an Associate Fellow of the Higher Education Academy, Affiliate of the Endocrine Society, Affiliate of the Physiological Society and Associate Member of the Royal Society of Biology. Her PhD research is in hyperinsulinemia and ketogenic sciences. Her work involves human intervention trials and ex vivo work, with samples from research participants.

Isabella Cooper
Prof Karol Sikora
Chief Medical Officer of Rutherford Health
Karol was the founder of Cancer Partners UK which has created the UK’s largest independent cancer network with private equity. He was Professor and Chairman of the Department of Cancer Medicine at Imperial College School of Medicine and is still honorary Consultant Oncologist at Hammersmith Hospital, London. He was seconded to be Director of the WHO Cancer Programme in 2000

He was the Founding Dean and now Professor of Medicine at Britain’s first independent Medical School at the University of Buckingham and a Fellow of Corpus Christi College, Cambridge. He has published over 300 papers and written or edited 20 books including Treatment of Cancer – the standard British postgraduate textbook, now going to its seventh edition in over 30 years. His book, The street-wise patients guide to surviving cancer was published recently. Nearly a year ago, he joined Twitter and now has over three hundred thousand followers. During the Covid crisis he has been dubbed the Positive Professor.

Prof Karol Sikora
Dr John Flack
Retired Pharmaceutical R&D Scientist
John has spent 40 years working in senior R&D and executive positions in the pharmaceutical and biotechnology industry. After graduating in pharmacy from London University he attained his PhD in the Dept. of Pharmacology, School of Pharmacy, London University. He then did a post-doctoral fellowship at the Worcester Foundation for Experimental Biology in Massachusetts, U.S.A.

He held senior positions in Research and Development at Smith Kline Beecham and Beecham Pharmaceuticals, during which time nabumetone (an anti-inflammatory), paroxetine (an anti-depressant), granisetron (an anti-emetic), Eminase (a thrombolytic), Augmentin (an oral anti-bacterial), Timentin (an injectable anti-bacterial), penciclovir/famciclovir (injectable/oral antivirals), Bactroban (a topical anti-bacterial) were discovered, developed and registered for marketing.

More recently, John has volunteered at his local vaccination centre helping the NHS roll out COVID-19 vaccines in the community.

Dr John Flack
Dr Roland Salmon, MRCGP, FFPH
Former Director of the Communicable Disease Surveillance Centre
Roland is a retired Consultant (Medical) Epidemiologist and former Director of the Communicable Disease Surveillance Centre (Wales) where he was responsible, for the surveillance and investigation of outbreaks, of infectious diseases as well as policy advice to government. He spent eight years as a member of the Department of Health’s Advisory Committee on Dangerous Pathogens (ACDP), including two years as acting chair and eight years as chair of its Transmissible Spongiform Encephalopathy (TSE) Working Group.

Recently, he has contributed to the COVID-19 debate, to date, via rapid responses in the British Medical Journal, a tribune-libre in Le Monde and letters to the London Review of Books, the Times and the Western Mail. As a Crematorium Medical Referee, he has peer-reviewed publication, in Epidemiology and Infection of a survey of the patients dying from COVID-19 whose cremations we authorised during the first wave of the pandemic. The key findings of this study were an average (median) age of 82 years with a median of 2 other serious comorbidities, as well as a quarter of the infections being acquired in hospital and a further quarter in the care sector.

Dr Roland Salmon
Prof Norman Fenton
Professor of Risk, Queen Mary University of London
As well as his position as Professor at QMUL

Norman is a mathematician whose current focus is on critical decision-making and, in particular, on quantifying uncertainty using causal, probabilistic models that combine data and knowledge.

His areas of work cover health, law and forensics, security, reliability, and transport safety.

Professor Norman Fenton
Dr Paul Cuddon
Healthcare and Life Sciences Research Analyst, London
Paul began his career as a PhD Student at the Babraham Institute in Cambridge studying the biology of neural networks and spent a year with Merck, Sharp and Dohme working on neural stem cells. He then undertook a postdoc at the Cambridge Institute of Medical Research discovering potential treatments for Huntington’s Disease.

He moved into equity research in 2007, and has been a top-ranked Healthcare Analyst for the last decade. He has written extensively on diagnostics for SARS-CoV-2 treatments and vaccines for COVID-19 and the collateral impact of the pandemic on a variety of business and healthcare services. His input into HART is in his personal capacity.

Dr Paul Cuddon
Dr Tanya Klymenko
Senior lecturer in Biomedical sciences
Tanya is a Fellow of the Higher Education Academy, a molecular biologist with 22 years laboratory experience and an expert in viral pathogen detection techniques including RT-PCR and metagenomics. She co-authored papers on host-virus interactions, biology of RNA viruses and B-cell malignancies.

Currently she is researching molecular mechanisms of the immune response and maintenance of immunological memory against pathogens. Her input into HART is in her personal capacity.

Dr Tanya Klymenko
Dr Clare Craig FRCPath
Diagnostic Pathologist
Clare has been a pathologist since 2001 working in the NHS and reaching consultant level in 2009.

She specialized in cancer diagnostics including diagnostic testing for cancer within mass screening programmes.

She was the day to day pathology lead for the cancer arm of the 100,000 Genomes Project. She was clinical lead for the data team and led on research and development projects at Genomics England and wrote national guidance and helped build bespoke software, working closely with NHSE. Subsequently she has worked on artificial intelligence for cancer diagnostics.

She is contributing to HART in a personal capacity.

Dr Gerry Quinn
Dr Jonathan Engler
Healthcare entrepreneur. Qualified in Medicine and Law
Jonathan initially trained in medicine, moving into the pharmaceutical sector where he worked on an international programme for a heart failure drug, designing and analysing clinical trials.

He then established a business which became a world-leader in using IT to co-ordinate and automate several clinical trial processes. Having sold that business, Jonathan then retrained as a barrister where he worked for a few years before moving back into business.

He is currently Chair for a business that is building a cancer stem-cell bank for use in oncology drug development.

Dr Jonathan Engler
Dr Malcolm Kendrick
General Practitioner, NHS
Malcolm is a Scottish GP, author and speaker. He has written two books, one which helps decipher medical jargon and one examining current theories about cholesterol and heart disease.

Dr Malcolm Kendrick
Dr Malcolm Loudon
Expert in Global Health and Disease Control
Malcolm has worked in the hospital and wider health sector in the United Kingdom and abroad.

He has extensive expertise in Global Health and mission specific knowledge of COVID-19 disease control, facility planning and delivery at pace and scale, medical force protection and key logistics.

He has extensive experience in trauma, emergency general and colorectal surgery. He has led regional services including cancer delivering change and service improvement consistently and effectively.

Dr Malcolm Loudon
Dr Gerry Quinn
Post-doctoral Researcher in Microbiology and Immunology
Gerry began his research career over 15 years ago in Florida working on the mechanisms by which pathogens are able to overcome human immunity mainly with multi-resistant hospital infections like MRSA but also with some work on anti-HIV peptides.

He then moved on to work on methods to overcome antibiotic resistant bacterial biofilms mainly through biosurfactants.

He is currently researching molecular signals in antibiotic production and the discovery of new antibiotics.

His input into HART is in his personal capacity.

Dr Gerry Quinn
Mr Tony Hinton MB. ChB., FRCS, FRCS(Oto)
Consultant ENT surgeon
Tony qualified in medicine and surgery in 1984 and trained in teaching hospitals in Birmingham, Manchester and London. He has published more than 30 research papers and was appointed as Consultant Surgeon to St George’s Hospital, London 1995. After working in the NHS for over 30 years, he is now semi-retired in independent practice and continues to see patients in clinic face-to-face and carry out surgery at two London hospitals.

Mr Tony Hinton
Dr Penelope Siebert
Lecturer in Public Health
Penny is a lecturer and the course leader for the MA Public Health programme at Nottingham Trent University.

Before entering academia she worked as a public health specialist in primary settings in the East Midlands. She has an interest in communicable disease control at a community level and with a specific interest in how the members of marginalised communities’ needs are articulated and recognised. She has research experience in evaluation with a special interest in the use of qualitative methodologies to elicit better understanding of in practice generation and use of evidence to improve programme and policy implementation, monitoring and evaluation.

Her PhD focused on exploring evaluation from the perspective of public health professionals. Her input into HART is in her personal capacity.

Dr Penelope Siebert
Dr Charlotte Bell
Immunologist and Veterinary Surgeon
Charlotte Bell is an experienced veterinary surgeon and immunologist. She worked for several years in clinical practice and taught at Edinburgh University vet school.

Following this she completed a PhD in immunology at the Roslin Institute, investigating adverse antibody responses to vaccination.

She continued at Roslin as a Research Fellow, focusing on the interactions of dendritic cells with T cells. This included pioneering a novel clinical method for the dynamic analysis of early immune responses to vaccination and how these influence adaptive responses. Since 2017, she has been a full-time mum

Dr Charlotte Bell
Dr Edmund Fordham
Fellow of the Institute of Physics
Edmund is a physicist and engineer, formerly Scientific Advisor to Schlumberger, and an independent Consultant since retiring in 2018. He is an experienced patient, a 23-yr survivor of Stage 4 lymphoma through what was at the time a clinical trial protocol in stem-cell transplantation.

He was an Independent Parliamentary Candidate at the General Election in 2019. Since March 2020, he has been tracking the use of repurposed drugs in the treatment and prophylaxis of COVID-19.

Dr Edmund Fordham
John Collis
Nurse Practitioner
John is currently a nurse practitioner working in a primary care urgent care centre and has 15 years experience as a registered nurse.

Previously he worked on a neurological ward for two years and in A&E for five years including paediatrics. Jon switched to being a triage nurse and has been in his current post for three years.

Prior to nursing Jon was a software engineer for 23 years in the defence industry.

In 2010 he had an article published in Emergency Nurse that examined the effects of crowding in an emergency department.

John Collis
Dr Keith Johnson
IP Consultant, Former Patent Examiner
Keith is a recently retired patent examiner with nearly thirty years experience in the field of diagnostic testing, including PCR, DNA chips and immunoassay.

He also holds a D.Phil from Oxford University in the field of Molecular Reaction Dynamics, which involved statistical modelling and chemometrics.

Dr Keith Johnson
Dr Renée Hoenderkamp
General Practitioner
Renée is a GP working in a busy North London practice. During the COVID-19 crisis she has worked in A&E as a GP ‘at the front door’ to triage and treat patients arriving. She has a special interest in women’s health and thyroid disease. She served on the NICE Guideline Committee for Thyroid disease and donates time to several large online women’s forums advising women on menopause and treatment. She has presented a documentary for BBC Inside Out on the poor treatment of women in menopause.

She is the BBC Radio London resident GP and writes regularly for The Daily Mail, MailPlus and PULSE Magazine.

Dr Renée Hoenderkamp
Dr Elizabeth Evans
Retired Doctor
Liz was formerly a GP registrar, then moved into the field of complementary medicine. She recently co-founded the UK Medical Freedom Alliance.

Liz is a member of PHIRE (Physicians’ Health Initiative for Radiation and Environment) and the BSEM (British Society for Ecological Medicine).

Dr Elizabeth Evans
Dr Alan Mordue
Retired Consultant in Public Health Medicine & Epidemiologist
Alan worked as a Consultant in Public Health Medicine & Epidemiologist for 28 years in Newcastle and Scotland and was an Honorary Clinical Senior Lecturer at the University of Edinburgh. Before Public Health training he worked clinically in hospital and general practice.

His interests include the prevention of cardiovascular disease, clinical epidemiology and evidence-based medicine, and the application of health economic principles and techniques in health care. After a brief return to the NHS in 2020 to support the response to COVID-19, he has retired from the fray once again.

“Dr
Dr Pedro Parreira
Lecturer in Physics and Astronomy, University of Glasgow
Pedro graduated in materials science in Lisbon in 2006 and moved to Glasgow for his PhD in 2011, where he ended up staying. Having researched thin film deposition and electron microscopy for approximately 10 years, he has slowly drifted towards scholarship of learning and teaching. In addition to coordinating and teaching on several courses, with emphasis on experimental physics, astronomy and computing, he is also a supervisor and adviser of studies.

He is contributing to HART solely in a personal capacity.

“Dr
Prof Alan Floyd
Professor of Education, University of Reading
Alan is Professor of Education at the University of Reading.

A former teacher, Alan’s research interests are focused on issues related to educational leadership and management in both compulsory and higher education, with the ultimate goal of positively impacting on student learning outcomes and experiences.

Prof Alan Floyd
Rev Dr William Philip MB ChB (Hons), MRCP, BD
Christian Minister and former Physician
William has been Senior Minister of The Tron Church, Glasgow, since 2004, now overseeing three venues across the city. Formerly Director of Ministry for The Proclamation Trust in London, he is chairman of Cornhill Scotland (a training institute for ministers), a trustee of The Christian Institute, and serves on the International Advisory Board of the Delhi Bible Institute.



He read medicine at The University Aberdeen and prior to ordination was training in cardiology at Aberdeen Royal Infirmary. He has written articles for various publications.

Rev William Philip
Members – Economics, Politics & Law
Prof Marilyn James
Professor of Health Economics, Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham
Marilyn is a health economist who has worked widely in economic evaluation and clinical trials. Resource and outcome valuation are some of her key interests.

She was on the National Screening Committee Antenatal Sub-group and has worked on diabetic eye screening for over 30 years. Additionally, she has experience of working in the Health Service and large pharma as a health economist.

Prof Marilyn James
Prof David Paton
Industrial Economics, Nottingham University Business School
David is Professor of Industrial Economics at Nottingham University Business School.

He has published widely in journals such as Economic Journal, Economica, Journal of Health Economics, Public Choice, Social Science & Medicine, Small Business Economics and the Journal of Economic Behavior and Organisation.

He has acted as an adviser to several Government departments including HM Revenue and Customs, Department for Culture, Media and Sport and the Department of Trade and Industry and is currently co-editor of the International Journal of the Economics of Business.

Prof David Paton
Dr Lee Jones
Reader in International Politics, Queen Mary University of London
Lee Jones has worked at QMUL since 2009, when he moved from the University of Oxford.

Lee specialises in political economy and international relations, focusing on the politics of intervention, security, and governance, with a particular interest in social conflict and the transformation of states. Much of his work focuses on Southeast Asia and China.

He is co-author of Governing Borderless Threats: Non-Traditional Security and the Politics of State Transformation (Cambridge University Press, 2015), which dealt with pandemic management, and “COVID-19 and the Failure of the Neoliberal Regulatory State”, forthcoming in Review of International Political Economy.

Dr Lee Jones
Members – Mental Health, Social Care and Education
Dr Gary Sidley
Retired Clinical Psychologist
Gary is a former Professional Lead/Consultant Clinical Psychologist after 33 continuous years of employment in the UK’s NHS.

He began his career as a psychiatric nurse in 1980, and qualified as a clinical psychologist in 1989. In 2000, he obtained his PhD for a thesis exploring the psychological predictors of suicidal behaviour.

Dr Gary Sidley
Prof Marcantonio Spada
Professor of Addictive Behaviours and Mental Health, London South Bank University
Marcantonio is a Chartered Psychologist with over 20 years’ experience spanning academia, psychological therapy, coaching and corporate training. As an academic and researcher, he has made a significant contribution to the field of psychological theory and therapy through the development of new metacognitive models and interventions for addictive behaviours, cyberchondria, procrastination and self-critical rumination. He was awarded a Fellowship from the British Psychological Society in recognition of this body of work.

More recently, Marcantonio has contributed to a growing body of literature regarding COVID-19-related psychological distress.

Prof Marcantonio Spada
Dr Livia Pontes
Clinical Psychologist
Dr Livia Pontes has 18 years of experience as a Clinical Psychologist. She has wealth of cross sector experience, having worked in the public and private sectors, as well as in primary, secondary and tertiary care. She has worked in Brazil, the USA and UK.

Here in the UK Livia has worked in the NHS at the Whittington Hospital in London and at Luton and Dunstable hospital, before dedicating her time completely to private practice.

She has also published a book about cognitive remediation of attention and memory for persons with schizophrenia.

Dr Livia Pontes
Dr Zenobia Storah
Child and Adolescent Clinical Psychologist
Zenobia studied for her doctorate at University College London, and specialised in working with children and adolescents.

She has worked in various CAMHS settings including generic CAMHS, children’s learning disability services and services for ‘Looked After’ and adopted children. In 2018, she left the NHS and now provides private therapy for children and young people, and services to NHS trusts as a private contractor.

She works mainly with children with neurodevelopmental conditions (autism, ADHD), and retains a strong interest in attachment and developmental trauma, providing Expert Witness services for the Family Courts.

Dr Zenobia Storah
Dr Harrie Bunker-Smith
Clinical Psychologist
Prior to training as a Clinical Psychologist, Harrie worked on various research trials at the Mood Disorders Centre, Exeter University and on research investigating parenting interventions with the University of York.

She expanded upon interests in nutrition and mental health during her doctoral thesis. Harrie has worked as a family support worker in Devon, gaining specialist experience within domestic abuse. During clinical psychology training in London, Harrie has worked across various NHS services including primary care, child development, forensic and ‘looked after children’.

Harrie has a specialist interest in attachment and currently works therapeutically with individual clients and through consultation with organisations.

Dr Harrie Bunker-Smith
Dr Elizabeth Corcoran
Psychiatrist and functional medicine doctor
Elizabeth is a Psychiatrist now working in Functional Medicine, is Chair of Down’s Syndrome Research Foundation UK (www.dsrf-uk.org) and has been working with PHE as a community stakeholder on the NHS Fetal Anomaly Screening Programme (FASP) Information and Education Sub-Group for the evaluative roll-out of NIPT testing.

Dr Elizabeth Corcoran
Prof David Seedhouse
Philosopher, author and software developer
David is owner and creator of the Values Exchange, an online tool for reflection and debate that has been used for almost two decades in universities and health care in the UK, Australia and New Zealand.

A widely read author in health philosophy, ethics and decision-making, David is also a best-selling author for Wiley.

Professor David Seedhouse
Sarah Waters
Psychotherapist and Therapeutic Parenting Practitioner
Sarah is experienced in working with the effects of abuse, neglect and childhood trauma. She also specialises in the family therapy and parenting model, Dyadic Developmental Practice (DDP). The DDP theory of trauma and brain development underpins the TIS and Thrive models in schools. In 2013 she set up a service for families affected by domestic abuse for a Cornwall charity and ran it for nearly 4 years.

Sarah’s knowledge of attachment theory means she is passionate about early intervention but constantly frustrated by its lack in our society. She also incorporates the transpersonal into her work seeking to provide harmony between mind, body and spirt. Prior to training to be a therapist in 2004 she worked in the field of PR and Marketing in London and Australia.

Sarah waters
Dr Val Fraser
Education Adviser
Val began working life as an English teacher in a secondary school. Later she taught post graduate students at the University of Nottingham. Her work took her around the world lecturing to international school teachers and she retired from the University in 2020.

She is also an education adviser for Nottinghamshire Local Authority reporting on home educated learners. Her specialist field is the most vulnerable children who often present with mental health issues and complex learning needs.

A subject expert for Ofqual and an Ofsted School Inspector, her subject expertise across all aspects of her work is in the field of creative pedagogues, conducive learning environments and collaborative talk for learning.

“Dr
Dr Ali Haggett
Former Lecturer in Mental Health
Ali was a former university lecturer and her research focuses on the history of mental illness, with a particular interest in gender and male suicide prevention. Her PhD examined the causes and treatment of depression in women since the 1950s.

She now works in the community, primarily with older people with complex medical problems, using reminiscence therapy and other holistic approaches to promote wellbeing.

“Dr
Dr Damian Wilde
Clinical Psychologist
Damian initially worked in education as a primary school teacher. After much work in child & adolescent mental health services (CAMHS), he completed a doctorate and then returned to further CAMHS practice, having carried out empirical research into the factors involved in childhood perfectionism.

After setting up a psychotherapy part of a therapies service, Damian began working in adult mental health. His main specialism is trauma psychotherapy but he also supports initiatives which look to tackle social inequality.

Dr Damian Wilde
HART is not currently in receipt of any funding following initial public donations which totalled £1,434.99. These funds have supported our website and set-


https://www.hartgroup.org/bios/
But he has nothing on at all, cried at last the whole people....
Post Reply

Return to “Covid 19 Pandemic - mRNA Vaccine Safety - Lockdowns”